DrugPatentWatch Database Preview
CIMZIA Drug Profile
Summary for Tradename: CIMZIA
| Patents: | 72 |
| Applicants: | 1 |
| BLAs: | 1 |
| Suppliers: see list | 1 |
| Drug Prices: | Drug price information for CIMZIA |
| Recent Clinical Trials: | See clinical trials for CIMZIA |
Recent Clinical Trials for CIMZIA
Identify potential brand extensions & biosimilar entrants
| Sponsor | Phase |
|---|---|
| University of California, San Francisco | Phase 1 |
| UCB Biopharma S.P.R.L. | Phase 3 |
| UCB Biopharma S.P.R.L. | Phase 2 |
Pharmacology for CIMZIA
| Mechanism of Action | Tumor Necrosis Factor Receptor Blocking Activity |
Patent Text Search: US Patents for CIMZIA
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ucb Inc | CIMZIA | certolizumab pegol | INJECTABLE; INJECTION | 125160 | 001 | 2008-04-22 | Start Trial | SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) | 2033-03-11 | RX | search | |
| Ucb Inc | CIMZIA | certolizumab pegol | INJECTABLE; INJECTION | 125160 | 001 | 2008-04-22 | Start Trial | Knopp Biosciences LLC (Pittsburgh, PA) | 2033-08-13 | RX | search | |
| Ucb Inc | CIMZIA | certolizumab pegol | INJECTABLE; INJECTION | 125160 | 001 | 2008-04-22 | Start Trial | Agency for Science, Technology and Research (Singapore, SG) | 2033-02-13 | RX | search | |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patents for CIMZIA
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Australia | 2005220211 | Start Trial |
| Australia | 2008254584 | Start Trial |
| Russian Federation | 2017118985 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
